Three phenotypes of adult-onset asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 5, 2013, Pages 674-680

  Amelink, M ^a   De Nijs, S B ^a   De Groot, J C ^b   Van Tilburg, P M B ^c   Van Spiegel, P I ^d   Krouwels, F H ^e   Lutter, R ^f   Zwinderman, A H ^f   Weersink, E J M ^a   Ten Brinke, A ^b   Sterk, P J ^a   Bel, E H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MEDICAL CENTER LEEUWARDEN   (Netherlands)

^c TERGOOI HOSPITAL   (Netherlands)

^d SLOTERVAART HOSPITAL   (Netherlands)

^e Infection and Immunology   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

adult onset asthma; asthma; cluster analysis; phenotypes

Indexed keywords

CORTICOSTEROID;

ADULT; ADULT ONSET ASTHMA; AGED; ARTICLE; ASTHMA; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GASTROESOPHAGEAL REFLUX; HEALTH CARE UTILIZATION; HUMAN; INFLAMMATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NETHERLANDS; OBESITY; PERSONALIZED MEDICINE; PHENOTYPE; PRIORITY JOURNAL; SPUTUM ANALYSIS; SYMPTOM;

ADULT; AGE OF ONSET; AGED; ASTHMA; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; EOSINOPHILS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SPUTUM;

EID: 84876547480     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12136     Document Type: Article

References (39)

1. National Institutes of Health. National Heart. Report: Lung and Blood Institute. Global initiative for asthma. Global strategy for asthma management and prevention. NHLBI/WHO workshop, 2006.
2. Wenzel SE,. Asthma: defining of the persistent adult phenotypes. Lancet 2006; 368: 804-813. (Pubitemid 44279058)
3. Miller MK, Johnson C, Miller DP, Deniz Y, Bleecker ER, Wenzel SE,. Severity assessment in asthma: an evolving concept. J Allergy Clin Immunol 2005; 116: 990-995. (Pubitemid 41571777)
4. Wenzel SE,. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012; 18: 716-725.
5. Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med 2010; 181: 315-323.
6. Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178: 218-224.
7. Siroux V, Basagana X, Boudier A, Pin I, Garcia-Aymerich J, Vesin A, et al. Identifying adult asthma phenotypes using a clustering approach. Eur Respir J 2011; 38: 310-317.
8. Miranda C, Busacker A, Balzar S, Trudeau J, Wenzel SE,. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 2004; 113: 101-108. (Pubitemid 38096168)
9. Thomsen SF, Ulrik CS, Kyvik KO, Larsen K, Skadhauge LR, Steffensen I, et al. The incidence of asthma in young adults. Chest 2005; 127: 1928-1934.
10. Ronmark E, Lindberg A, Watson L, Lundback B,. Outcome and severity of adult onset asthma-report from the obstructive lung disease in northern Sweden studies (OLIN). Respir Med 2007; 101: 2370-2377. (Pubitemid 47471398)
11. Ulrik CS, Lange P,. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 1994; 150: 629-634. (Pubitemid 24291487)
12. ten Brinke A, van Dissel JT, Sterk PJ, Zwinderman AH, Rabe KF, Bel EH,. Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J Allergy Clin Immunol 2001; 107: 449-454. (Pubitemid 32210024)
13. Jenkins HA, Cherniack R, Szefler SJ, Covar R, Gelfand EW, Spahn JD,. A comparison of the clinical characteristics of children and adults with severe asthma. Chest 2003; 124: 1318-1324. (Pubitemid 37290041)
14. Peat JK, Tovey E, Toelle BG, Haby MM, Gray EJ, Mahmic A, et al. House dust mite allergens. A major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med 1996; 153: 141-146. (Pubitemid 26026840)
15. Dahlberg PE, Busse WW,. Is intrinsic asthma synonymous with infection? Clin Exp Allergy 2009; 39: 1324-1329.
16. Venables KM, Chan-Yeung M,. Occupational asthma. Lancet 1997; 349: 1465-1469. (Pubitemid 27212205)
17. Bousquet J, Bachert C, Canonica GW, Casale TB, Cruz AA, Lockey RJ, et al. Unmet needs in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol 2009; 124: 428-433.
18. Jamrozik E, Knuiman MW, James A, Divitini M, Musk AW,. Risk factors for adult-onset asthma: a 14-year longitudinal study. Respirology 2009; 14: 814-821.
19. Beuther DA, Sutherland ER,. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007; 175: 661-666. (Pubitemid 46536480)
20. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC,. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. official statement of the European respiratory society. Eur Respir J Suppl 1993; 16: 5-40.
21. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR,. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14: 902-907. (Pubitemid 29519356)
22. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK,. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47: 76-83.
23. Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP,. Psychometric validity of the 22-item sinonasal outcome test. Clin Otolaryngol 2009; 34: 447-454.
24. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338. (Pubitemid 41079078)
25. Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O'Byrne PM, Anderson SD, et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report working party standardization of lung function tests, European community for steel and coal. official statement of the European respiratory society. Eur Respir J Suppl 1993; 16: 53-83.
26. ATS/ERS recommendations for standardized procedures for the online and offline measurements of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 2005; 171: 912-930.
27. ten Brinke A, de Lange C, Zwinderman AH, Rabe KF, Sterk PJ, Bel EH,. Sputum induction in severe asthma by a standardized protocol: predictors of excessive bronchoconstriction. Am J Respir Crit Care Med 2001; 164: 749-753. (Pubitemid 32881908)
28. Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J, et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax 2010; 66: 910-917.
29. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360: 1715-1721. (Pubitemid 35447900)
30. V Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH,. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 2001; 164: 744-748. (Pubitemid 32881907)
31. Ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH,. "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am J Respir Crit Care Med 2004; 170: 601-605. (Pubitemid 39202200)
32. Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, et al. Mepoli-zumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 2012; 380: 651-659.
33. van Veen IH, ten Brinke A, Sterk PJ, Rabe KF, Bel EH,. Airway inflammation in obese and nonobese patients with difficult-to-treat asthma. Allergy 2008; 63: 570-574. (Pubitemid 351490394)
34. Sutherland ER, Lehman EB, Teodorescu M, Wechsler ME,. Body mass index and phenotype in subjects with mild-to-moderate persistent asthma. J Allergy Clin Immunol 2009; 123: 1328-1334.
35. Shore SA,. Obesity and asthma: possible mechanisms. J Allergy Clin Immunol 2008; 121: 1087-1093.
36. Sideleva O, Suratt BT, Black KE, Tharp WG, Pratley RE, Forgione P, et al. Obesity and Asthma: an inflammatory disease of adipose tissue not the airway. Am J Respir Crit Care Med 2012; 186: 598-605.
37. Kim TB, Jang AS, Kwon HS, Park JS, Chang YS, Cho SH, et al. Identification of asthma clusters in two independent Korean adult asthma cohorts. Eur Respir J 2012; (Epub ahead of print).
38. Toren K, Palmqvist M, Lowhagen O, Balder B, Tunsater A,. Self-reported asthma was biased in relation to disease severity while reported year of asthma onset was accurate. J Clin Epidemiol 2006; 59: 90-93. (Pubitemid 41797480)
39. Murphy AC, Proeschal A, Brightling CE, Wardlaw AJ, Pavord I, Bradding P, et al. The relationship between clinical outcomes and medication adherence in difficult-to-control asthma. Thorax 2012; 67: 751-753.